Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-26

FDA Approved: ZUNVEYL — Original Application (Alpha Cognition, Inc.)

View source ↗

Summary

The FDA approved ZUNVEYL (benzgalantamine) from Alpha Cognition, Inc. via an original NDA, adding a new treatment option for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZUNVEYL (Benzgalantamine)

Snippet

ORIG AP for ZUNVEYL (BENZGALANTAMINE)